NRX Pharmaceuticals Inc (NRXP)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current NRXP market cap is 18.14M. The company's latest EPS is USD -2.7682 and P/E is -0.60.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.19M | -5.81M | -4.41M | -6M | -7.05M |
| Net Income | -8.72M | -6.06M | -4.34M | -6.53M | -7.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 10.16M | 771k | 0 | 0 |
| Operating Income | -713k | -51.39M | -115.8M | -44.34M | -27.84M |
| Net Income | 408k | -51M | -348.89M | -39.75M | -30.16M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.81M | 13.11M | 7.32M | 3.79M | 5.26M |
| Total Liabilities | 22.62M | 19.33M | 19.05M | 18.86M | 23.66M |
| Total Equity | -2.81M | -6.22M | -11.73M | -15.07M | -18.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.08M | 2.94M | 32.73M | 25.82M | 7.32M |
| Total Liabilities | 2.58M | 46.72M | 11.92M | 18.41M | 19.05M |
| Total Equity | 5M | -43.78M | 20.81M | 7.41M | -11.73M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.9M | -18.47M | -21.66M | -3.67M | -6.23M |
| Investing | -2k | -4k | -3k | N/A | N/A |
| Financing | 8.82M | 7.32M | 6.2M | 395k | 3.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -793k | -2.27M | -37.7M | -39.76M | -21.66M |
| Investing | 40.25M | -1,000 | -7k | -10k | -3k |
| Financing | -39.47M | 3.25M | 63.46M | 32.21M | 6.2M |
| Market Cap | 18.14M |
| Price to Earnings Ratio | -0.60 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.96 |
| Price to Book Ratio | -1.55 |
| Dividend Yield | - |
| Shares Outstanding | 10.89M |
| Average Volume (1 week) | 176.72k |
| Average Volume (1 Month) | 109.41k |
| 52 Week Change | -33.40% |
| 52 Week High | 7.333 |
| 52 Week Low | 1.59 |
| Spread (Intraday) | 0.05 (2.96%) |
| Company Name | NRX Pharmaceuticals Inc |
| Address |
1201 orange st wilmington, delaware 19801 |
| Website | https://www.nrxpharma.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
